News
As the new school year begins, we invite you to discover our tips for strengthening your child's immunity. Good health is key to helping them grow and learn in the best possible conditions.
For two decades, IPProton, the famous proton pump inhibitor developed by MédiS laboratories, has been celebrating its twentieth anniversary.
The evaluation of sperm DNA integrity is recommended in the sixth edition of the 2021 World Health Organization guidelines. Oxidative stress has been identified as a crucial factor leading to genome decay, lipid peroxidation, and nucleoprotein oxidation.
MédiS Laboratories and Neapolis were honored by a delegation from the Regional Council of Pharmacists from the Northwest. This occasion provided an opportunity for immersion in the local pharmaceutical industry's expertise.
Fondés en 1995, les Laboratoires MediS sont aujourd’hui non seulement le leader du marché tunisien des médicaments génériques, mais aussi un acteur clé de l'industrie pharmaceutique internationale.
Dear Sisters and Brothers,
MédiS, a major player in the Tunisian pharmaceutical industry, announces the launch of the first biosimilar of Glargine insulin for diabetes treatment on February 18, 2022, following approval from the Ministry of Health.
In the realm of personal protective equipment, non-medical masks, also known as barrier masks or cloth masks, serve as individual protection for the general public and should not be used by healthcare professionals in direct contact with patients. (1, 4)
Telecommuting refers to working for an employer outside of the workplace. In exceptional circumstances, such as the coronavirus epidemic, this practice can be imposed on employees without their consent.
MediS, dedicated to serving health, embodies our laboratory's philosophy. Over the years, we have consistently provided patients with high-quality medications while ensuring cost-effectiveness in managing their conditions, particularly pain.
On March 2, 2015, MédiS obtained authorization to market the first human-origin recombinant alpha erythropoietin (EPO), marking a significant milestone in the Tunisian pharmaceutical industry.